Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-06 Purchase | 2019-08-08 2:26 pm | OBALON THERAPEUTICS INC | OBLN | VandenBerg Amy Chief Clinical & Reg Officer | 2,500 | $4 | $10,000 | 13,639 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-24 Option Award | 2020-01-28 4:30 pm | N/A N/A | OBALON THERAPEUTICS INC | OBLN | VandenBerg Amy Chief Clinical & Reg Officer | 88,225 | $0 | 88,225 (Direct) | View |
| 2019-10-25 Option Award | 2019-10-28 4:40 pm | N/A 2029-10-25 | OBALON THERAPEUTICS INC | OBLN | VandenBerg Amy Chief Clinical & Reg Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-10-25 Option Award | 2019-10-28 4:40 pm | N/A 2029-10-25 | OBALON THERAPEUTICS INC | OBLN | VandenBerg Amy Chief Clinical & Reg Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-07-23 Option Award | 2019-07-25 4:30 pm | N/A 2029-07-23 | OBALON THERAPEUTICS INC | OBLN | VandenBerg Amy Chief Clinical & Reg Officer | 35,000 | $0 | 35,000 (Direct) | View |